News

Company News

Paradromics Accepted to FDA Regulatory Accelerator Program and Announces New Patient Registry

Read more

Paradromics CEO Matt Angle on the Neuralink Demo

Read more

Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA

Read more

The Neurotech Revolution goes (back) to Washington!

Read more

Paradromics CEO Matt Angle at NANS 2023

Read more

The Neurotech Revolution goes to Washington!

Read more

Paradromics Announces Neurotech Track at Built with Biology 2022

Read more

Paradromics Announces NIH Award to Fund Translational and Early-Stage Clinical Research

Read more

Paradromics Raises $20MM in Seed Funding Led by Prime Movers Lab to Advance Brain Computer Interfaces

Read more

Paradromics Develops Precision Laser Surgical Tool that can be Used to Aid BCI Implantation

Read more

Paradromics Featured on Loup Ventures’ Neurotech podcast

Read more